The inhibitory effect of RE on PRL synthesis may be useful in the treatment of prolactinoma, particularly with microprolactinoma where the predominant aim of therapy is to decrease the high level of PRL and improve endocrine symptoms. The gene discussed is PRL; the disease is Microprolactinoma.